Metformin Inhibits Cyst Formation in a Zebrafish Model of Polycystin-2 Deficiency

Abstract Autosomal dominant polycystic kidney disease (ADPKD) is a common kidney disease caused by mutations in PKD1 or PKD2. Metformin reduces cyst growth in mouse models of PKD1. However, metformin has not been studied in animal models of PKD2, and the cellular mechanism underlying its effectivene...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ming-Yang Chang, Tsu-Lin Ma, Cheng-Chieh Hung, Ya-Chung Tian, Yung-Chang Chen, Chih-Wei Yang, Yi-Chuan Cheng
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7b073746b7fe4a018b85d35f2d1d0e2b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7b073746b7fe4a018b85d35f2d1d0e2b
record_format dspace
spelling oai:doaj.org-article:7b073746b7fe4a018b85d35f2d1d0e2b2021-12-02T15:06:21ZMetformin Inhibits Cyst Formation in a Zebrafish Model of Polycystin-2 Deficiency10.1038/s41598-017-07300-x2045-2322https://doaj.org/article/7b073746b7fe4a018b85d35f2d1d0e2b2017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-07300-xhttps://doaj.org/toc/2045-2322Abstract Autosomal dominant polycystic kidney disease (ADPKD) is a common kidney disease caused by mutations in PKD1 or PKD2. Metformin reduces cyst growth in mouse models of PKD1. However, metformin has not been studied in animal models of PKD2, and the cellular mechanism underlying its effectiveness is not entirely clear. This study investigated the effects of metformin on cyst formation in a zebrafish model of polycystin-2 deficiency resulting from morpholino knockdown of pkd2. We added metformin (2.5 to 20 mM) to the embryo media between 4 and 48 hours post fertilisation and observed pronephric cyst formation by using the wt1b promoter-driven GFP signal in Tg(wt1b:GFP) pkd2 morphants. Metformin inhibited pronephric cyst formation by 42–61% compared with the untreated controls. Metformin also reduced the number of proliferating cells in the pronephric ducts, the degree of dorsal body curvature, and the infiltration of leukocytes surrounding the pronephros. Moreover, metformin treatment increased the phosphorylation of adenosine monophosphate-activated protein kinase (AMPK) and enhanced autophagy in the pronephros. Our data suggest that metformin reduces cyst formation through activation of the AMPK pathway and modulation of defective cellular events such as proliferation and autophagy. These results also imply that metformin could have therapeutic potential for ADPKD treatment.Ming-Yang ChangTsu-Lin MaCheng-Chieh HungYa-Chung TianYung-Chang ChenChih-Wei YangYi-Chuan ChengNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ming-Yang Chang
Tsu-Lin Ma
Cheng-Chieh Hung
Ya-Chung Tian
Yung-Chang Chen
Chih-Wei Yang
Yi-Chuan Cheng
Metformin Inhibits Cyst Formation in a Zebrafish Model of Polycystin-2 Deficiency
description Abstract Autosomal dominant polycystic kidney disease (ADPKD) is a common kidney disease caused by mutations in PKD1 or PKD2. Metformin reduces cyst growth in mouse models of PKD1. However, metformin has not been studied in animal models of PKD2, and the cellular mechanism underlying its effectiveness is not entirely clear. This study investigated the effects of metformin on cyst formation in a zebrafish model of polycystin-2 deficiency resulting from morpholino knockdown of pkd2. We added metformin (2.5 to 20 mM) to the embryo media between 4 and 48 hours post fertilisation and observed pronephric cyst formation by using the wt1b promoter-driven GFP signal in Tg(wt1b:GFP) pkd2 morphants. Metformin inhibited pronephric cyst formation by 42–61% compared with the untreated controls. Metformin also reduced the number of proliferating cells in the pronephric ducts, the degree of dorsal body curvature, and the infiltration of leukocytes surrounding the pronephros. Moreover, metformin treatment increased the phosphorylation of adenosine monophosphate-activated protein kinase (AMPK) and enhanced autophagy in the pronephros. Our data suggest that metformin reduces cyst formation through activation of the AMPK pathway and modulation of defective cellular events such as proliferation and autophagy. These results also imply that metformin could have therapeutic potential for ADPKD treatment.
format article
author Ming-Yang Chang
Tsu-Lin Ma
Cheng-Chieh Hung
Ya-Chung Tian
Yung-Chang Chen
Chih-Wei Yang
Yi-Chuan Cheng
author_facet Ming-Yang Chang
Tsu-Lin Ma
Cheng-Chieh Hung
Ya-Chung Tian
Yung-Chang Chen
Chih-Wei Yang
Yi-Chuan Cheng
author_sort Ming-Yang Chang
title Metformin Inhibits Cyst Formation in a Zebrafish Model of Polycystin-2 Deficiency
title_short Metformin Inhibits Cyst Formation in a Zebrafish Model of Polycystin-2 Deficiency
title_full Metformin Inhibits Cyst Formation in a Zebrafish Model of Polycystin-2 Deficiency
title_fullStr Metformin Inhibits Cyst Formation in a Zebrafish Model of Polycystin-2 Deficiency
title_full_unstemmed Metformin Inhibits Cyst Formation in a Zebrafish Model of Polycystin-2 Deficiency
title_sort metformin inhibits cyst formation in a zebrafish model of polycystin-2 deficiency
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/7b073746b7fe4a018b85d35f2d1d0e2b
work_keys_str_mv AT mingyangchang metformininhibitscystformationinazebrafishmodelofpolycystin2deficiency
AT tsulinma metformininhibitscystformationinazebrafishmodelofpolycystin2deficiency
AT chengchiehhung metformininhibitscystformationinazebrafishmodelofpolycystin2deficiency
AT yachungtian metformininhibitscystformationinazebrafishmodelofpolycystin2deficiency
AT yungchangchen metformininhibitscystformationinazebrafishmodelofpolycystin2deficiency
AT chihweiyang metformininhibitscystformationinazebrafishmodelofpolycystin2deficiency
AT yichuancheng metformininhibitscystformationinazebrafishmodelofpolycystin2deficiency
_version_ 1718388522661969920